DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods.

[1]  Chien-Jen Chen,et al.  Quality assurance of genotyping array for detection and typing of human papillomavirus. , 2007, Journal of virological methods.

[2]  S. Wacholder,et al.  Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. , 2006, Cancer research.

[3]  Francisco A. R. Garcia,et al.  Pilot Study of a Commercialized Human Papillomavirus (HPV) Genotyping Assay: Comparison of HPV Risk Group to Cytology and Histology , 2006, Journal of Clinical Microbiology.

[4]  S. Garland,et al.  Assessment of MagNA Pure LC Extraction System for Detection of Human Papillomavirus (HPV) DNA in PreservCyt Samples by the Roche AMPLICOR and LINEAR ARRAY HPV Tests , 2006, Journal of Clinical Microbiology.

[5]  E. Benini,et al.  Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples , 2006, Journal of Clinical Microbiology.

[6]  Xavier Castellsagué,et al.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. , 2006, Journal of the National Cancer Institute.

[7]  C. Wheeler,et al.  A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears. , 2005, American journal of clinical pathology.

[8]  E. Sugar,et al.  Analysis of the Effect of DNA Purification on Detection of Human Papillomavirus in Oral Rinse Samples by PCR , 2005, Journal of Clinical Microbiology.

[9]  David R. Scott,et al.  The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.

[10]  R. DeSalle,et al.  The carcinogenicity of human papillomavirus types reflects viral evolution. , 2005, Virology.

[11]  W. Quint,et al.  Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche AMPLICOR HPV Test as a Means To Screen for HPV Genotypes Associated with a Higher Risk of Cervical Disorders , 2005, Journal of Clinical Microbiology.

[12]  M. Stoler.  Human papillomavirus biology and cervical neoplasia: implications for diagnostic criteria and testing. , 2003, Archives of pathology & laboratory medicine.

[13]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[14]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[15]  W. Quint,et al.  Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic , 2002, Journal of medical virology.

[16]  M. Schiffman,et al.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. , 2001, Journal of the National Cancer Institute.

[17]  C. Meijer,et al.  Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study , 1999, The Lancet.

[18]  C. Peyton,et al.  Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method , 1998, Journal of Clinical Microbiology.

[19]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .